Javed Mahmood

760 total citations
24 papers, 565 citations indexed

About

Javed Mahmood is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Javed Mahmood has authored 24 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Javed Mahmood's work include Effects of Radiation Exposure (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Javed Mahmood is often cited by papers focused on Effects of Radiation Exposure (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Javed Mahmood collaborates with scholars based in United States, Canada and Japan. Javed Mahmood's co-authors include Rićhard P. Hill, Salomeh Jelveh, Susan R. Doctrow, Meetha Medhora, Jake Van Dyk, Ivan Yeung, Karl Huffman, John E. Moulder, Brian L. Fish and Stephen T. Sonis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Kidney International.

In The Last Decade

Javed Mahmood

24 papers receiving 555 citations

Peers

Countries citing papers authored by Javed Mahmood

Since Specialization

Citations

This map shows the geographic impact of Javed Mahmood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javed Mahmood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javed Mahmood more than expected).

Fields of papers citing papers by Javed Mahmood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javed Mahmood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javed Mahmood. The network helps show where Javed Mahmood may publish in the future.

Co-authorship network of co-authors of Javed Mahmood

This figure shows the co-authorship network connecting the top 25 collaborators of Javed Mahmood. A scholar is included among the top collaborators of Javed Mahmood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javed Mahmood. Javed Mahmood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Five-year outcomes with first-line (1L) nivolumab + ipilimumab + chemotherapy (N + I + C) vs C in patients (pts) with metastatic NSCLC (mNSCLC) in CheckMate 9LA. 2024 ·Journal of Clinical Oncology ·Martin Reck, Tudor–Eliade Ciuleanu, Michael Schenker, Stéphanie Bordenave-Juchereau, Manuel Cobo, Óscar Juan, Niels Reinmuth, Eduardo Richardet, Enriqueta Felip, J. Menezes, Ying Cheng, Hideaki Mizutani, David P. Carbone, Shun Lü, Thomas John, (unknown), Javed Mahmood, Nan Hu, Laura J. Eccles, Luis Paz‐Ares	6
2	Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with resectable NSCLC: 4-year update from CheckMate 816. 2024 ·Journal of Clinical Oncology ·Jonathan Spicer, Nicolas Girard, Mariano Provencio, Changli Wang, Tetsuya Mitsudomi, Mark M. Awad, Everett E. Vokes, Janis M. Taube, Lorena Lupinacci, Gene Saylors, Fumihiro Tanaka, Moïshe Liberman, Sung Yong Lee, Aurelia Alexandru, M. D’Arcangelo, Phuong Tran, Javed Mahmood, (unknown), (unknown), Patrick M. Forde	25
3	1261O Neoadjuvant nivolumab (N) + ipilimumab (I) vs chemotherapy (C) in the phase III CheckMate 816 trial 2023 ·Annals of Oncology ·Mark M. Awad, Patrick M. Forde, Nicolas Girard, (unknown), (unknown), Shun Lü, (unknown), Enriqueta Felip, Stephen Broderick, Scott J. Swanson, (unknown), Keith M. Kerr, (unknown), (unknown), (unknown), Javed Mahmood, (unknown), David Balli, Nan Hu, Mariano Provencio	14
4	LBA57 Neoadjuvant nivolumab (N) + chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression 2023 ·Annals of Oncology ·Mariano Provencio, Patrick M. Forde, (unknown), C. Wang, Shun Lu, Tetsuya Mitsudomi, Mark M. Awad, Enriqueta Felip, Stephen Broderick, Steven Swanson, Julie R. Brahmer, Keith M. Kerr, (unknown), Fumihiro Tanaka, (unknown), (unknown), (unknown), Javed Mahmood, S. Meadows–Shropshire, Nicolas Girard	13
5	Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816 2023 ·Cancer Science ·Tetsuya Mitsudomi, Hiroyuki Ito, Morihito Okada, Shunichi Sugawara, Yutaka Shio, Keisuke Tomii, Jiro Okami, Noriaki Sakakura, Kaoru Kubota, Kazuya Takamochi, Shinji Atagi, Masahiro Tsuboi, Satoshi Oizumi, Norihiko Ikeda, Yasuhisa Ohde, (unknown), Javed Mahmood, Junliang Cai, Fumihiro Tanaka	12
6	Clinical outcomes with neoadjuvant nivolumab (N) + chemotherapy (C) vs C by definitive surgery in patients (pts) with resectable NSCLC: 3-y results from the phase 3 CheckMate 816 trial. 2023 ·Journal of Clinical Oncology ·Jonathan Spicer, Patrick M. Forde, Mariano Provencio, Shun Lü, Changli Wang, Tetsuya Mitsudomi, Stephen Broderick, Steven Swanson, Mark M. Awad, Enriqueta Felip, Julie R. Brahmer, Keith M. Kerr, Gene Saylors, Ke‐Neng Chen, Fumihiro Tanaka, Junliang Cai, Javed Mahmood, Nan Hu, Phuong Tran, Nicolas Girard	13
7	Abstract CT012: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment for resectable (IB-IIIA) non-small cell lung cancer (NSCLC): Event-free survival (EFS) results from the phase 3 CheckMate 816 trial 2022 ·Cancer Research ·Nicolas Girard, Jonathan Spicer, Mariano Provencio, Shun Lü, Stephen Broderick, Mark M. Awad, Tetsuya Mitsudomi, Keith M. Kerr, Julie R. Brahmer, Steven Swanson, Enriqueta Felip, Changli Wang, Gene Saylors, Ke‐Neng Chen, Fumihiro Tanaka, Moïshe Liberman, Cécile Dorange, Javed Mahmood, Junliang Cai, Patrick M. Forde	6
8	Exploring the Concept of Radiation "Booster Shot" in Combination with an Anti-PD-L1 mAb to Enhance Anti-Tumor Immune Effects in Mouse Pancreas Tumors. 2017 ·PubMed ·Michael D. Chuong, (unknown), Eun Yong Choi, Javed Mahmood, Rena G. Lapidus, Eduardo Dávila, France Carrier	11
9	In Vitro and In Vivo Studies of a New Class of Anticancer Molecules for Targeted Radiotherapy of Cancer 2016 ·Molecular Cancer Therapeutics ·(unknown), Javed Mahmood, Qinrong Zhang, Ali Vedadi, (unknown), Ning Ou, Robert G. Bristow, David A. Jaffray, Qing‐Bin Lu	9
10	Pilot Study Evaluating a Rat Model of Radiation-induced Erectile Dysfunction Using an Image-guided Microirradiator 2015 ·Urology ·Masaki Kimura, (unknown), Javed Mahmood, Shiva K. Das, (unknown), Isabel L. Jackson, Željko Vujašković	12
11	Targeting the Renin–Angiotensin System Combined With an Antioxidant Is Highly Effective in Mitigating Radiation-Induced Lung Damage 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Javed Mahmood, Salomeh Jelveh, (unknown), Susan R. Doctrow, Meetha Medhora, Rićhard P. Hill	42
12	Investigations of antioxidant-mediated protection and mitigation of radiation-induced DNA damage and lipid peroxidation in murine skin 2013 ·International Journal of Radiation Biology ·Salomeh Jelveh, Pavel Kaspler, Nirmal Bhogal, Javed Mahmood, Patricia Lindsay, Paul Okunieff, Susan R. Doctrow, Robert G. Bristow, Rićhard P. Hill	25
13	Effects of lipopolysaccharide on the response of C57BL/6J mice to whole thorax irradiation 2012 ·Radiotherapy and Oncology ·(unknown), Salomeh Jelveh, Javed Mahmood, Rićhard P. Hill	19
14	Investigations into the role of inflammation in normal tissue response to irradiation 2011 ·Radiotherapy and Oncology ·Rićhard P. Hill, (unknown), Javed Mahmood, Salomeh Jelveh	59
15	Salen Mn Complexes Mitigate Radiation Injury in Normal Tissues 2011 ·Anti-Cancer Agents in Medicinal Chemistry ·Rosalind A. Rosenthal, Brian L. Fish, Rićhard P. Hill, Karl Huffman, Zelmira Lazarova, Javed Mahmood, Meetha Medhora, Robert C. Molthen, John E. Moulder, Stephen T. Sonis, Philip J. Tofilon, Susan R. Doctrow	59
16	Mitigation of radiation-induced lung injury by genistein and EUK-207 2011 ·International Journal of Radiation Biology ·Javed Mahmood, Salomeh Jelveh, (unknown), (unknown), Susan R. Doctrow, Rićhard P. Hill	72
17	Mitigation of Lung Injury after Accidental Exposure to Radiation 2011 ·Radiation Research ·Javed Mahmood, Salomeh Jelveh, (unknown), (unknown), Susan R. Doctrow, Rićhard P. Hill	34
18	Genistein Can Mitigate the Effect of Radiation on Rat Lung Tissue 2010 ·Radiation Research ·(unknown), Salomeh Jelveh, (unknown), Javed Mahmood, Ivan Yeung, Jake Van Dyk, Rićhard P. Hill	67
19	Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis 2006 ·Kidney International ·Javed Mahmood, Fahima Khan, Shinichi Okada, Naonori Kumagai, T. Morioka, Takashi Oite	16
20	Alterations of Cell Adhesion Molecules in Human Glomerular Endothelial Cells in Response to Nephritis-Associated Plasminogen Receptor 2006 ·Nephron Experimental Nephrology ·Fahima Khan, Kazuo Yamakami, Javed Mahmood, Bing Li, (unknown), Naoki Kumagai, Tetsuo Morioka, Nobuyuki Yoshizawa, Takashi Oite	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact